Over the past year there were no insider purchases at Revolution Medicines, Inc.. 12 insiders sold roughly $157.3 million instead.
Keep in mind most insider selling is routine — stock-based pay has to be converted to cash at some point.
On the institutional side, 690 funds reported holding RVMD at the end of Q2 2026, and more funds bought than sold. 7 quarters in a row of net selling by insiders. Insiders bought in 0 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | Sandler Alan B. | Executive Officer | Sell | 1,609 | $201.72 | $325K | SEC |
| Oct 1, 2026 | Sandler Alan B. | Executive Officer | Sell | 1,199 | $203.91 | $244K | SEC |
| Oct 1, 2026 | Sandler Alan B. | Executive Officer | Sell | 2,200 | $200.82 | $442K | SEC |
| Oct 1, 2026 | Sandler Alan B. | Executive Officer | Sell | 1,000 | $202.81 | $203K | SEC |
| Oct 1, 2026 | Sandler Alan B. | Executive Officer | Sell | 301 | $204.72 | $62K | SEC |
| Sep 29, 2026 | Cislini Jeff | Executive Officer | Sell | 765 | $207.32 | $159K | SEC |
| Sep 28, 2026 | Mancini Anthony | Officer | Sell | 3,121 | $200.54 | $626K | SEC |
| Sep 28, 2026 | Mancini Anthony | Officer | Sell | 587 | $200.00 | $117K | SEC |
| Sep 24, 2026 | ANDERSON ELIZABETH M | Director | Sell | 100 | $195.15 | $20K | SEC |
| Sep 24, 2026 | ANDERSON ELIZABETH M | Director | Sell | 2,648 | $193.44 | $512K | SEC |
| Sep 24, 2026 | ANDERSON ELIZABETH M | Director | Sell | 4,985 | $192.54 | $960K | SEC |
| Sep 24, 2026 | ANDERSON ELIZABETH M | Director | Sell | 910 | $191.85 | $175K | SEC |
| Sep 24, 2026 | ANDERSON ELIZABETH M | Director | Sell | 1,500 | $194.59 | $292K | SEC |
| Sep 22, 2026 | Mancini Anthony | Officer | Sell | 1,764 | $196.94 | $347K | SEC |
| Sep 18, 2026 | Kelsey Stephen Michael | Officer | Sell | 85 | $195.01 | $17K | SEC |
In the last 12 months Revolution Medicines, Inc. insiders made open-market purchases worth about $0 and sales worth about $157.3 million. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in RVMD was filed on 2026-10-01.
690 investment managers reported holding RVMD in SEC Form 13F filings for Q2 2026.
No congressional trades in RVMD were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).